US Stock MarketDetailed Quotes
KPRX Kiora Pharmaceuticals
- 3.6750
- +0.0750+2.08%
Close Nov 4 16:00 ET
- 3.7300
- +0.0550+1.50%
Post 18:36 ET
10.92MMarket Cap-634P/E (TTM)
3.7400High3.4600Low32.36KVolume3.6100Open3.6000Pre Close117.38KTurnover2.39%Turnover RatioLossP/E (Static)2.97MShares8.982052wk High0.33P/B4.98MFloat Cap3.000052wk Low--Dividend TTM1.36MShs Float189000.0000Historical High--Div YieldTTM7.78%Amplitude3.0000Historical Low3.6260Avg Price1Lot Size
Kiora Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -169.58%-3.73M | 543.87%13.62M | 8.35%-9.56M | -21.25%-2.58M | 15.05%-2.52M | 44.58%-1.38M | -8.37%-3.07M | 2.32%-10.43M | 27.08%-2.13M | -30.73%-2.97M |
| Net income from continuing operations | 15.00%-2.22M | 819.99%13.45M | 7.88%-12.51M | 9.20%-2.27M | -12.57%-5.76M | -8.87%-2.61M | 47.59%-1.87M | 1.36%-13.58M | 59.59%-2.5M | -68.69%-5.12M |
| Operating gains losses | ---- | ---- | -101.79%-25.5K | ---- | ---- | ---- | ---- | 610.76%1.42M | --0 | --1.43M |
| Depreciation and amortization | -71.84%6.33K | -51.69%4.87K | 24.49%51.8K | -22.85%7.94K | 10.11%11.31K | 118.63%22.48K | -6.45%10.08K | -8.14%41.61K | -6.81%10.29K | -7.12%10.27K |
| Deferred tax | ---- | ---- | 179.92%90.32K | ---- | ---- | ---- | ---- | 41.32%-113.01K | ---- | ---- |
| Other non cash items | -16.20%149.03K | -100.35%-851 | 196.73%2M | 190.93%39.01K | 324.48%1.54M | 157.43%177.84K | -15.19%241.7K | 308.54%675.02K | -49.30%-42.9K | 216.02%363.85K |
| Change In working capital | -301.66%-1.73M | 99.51%-7.81K | -372.54%-1.82M | -229.13%-606.84K | -317.46%-483.12K | 444.44%856.78K | -805.65%-1.59M | 164.54%668.51K | 160.39%469.95K | -54.57%222.16K |
| -Change in receivables | -284.83%-1.64M | 96.74%-10.82K | 37.20%-548.11K | -275.57%-529.11K | 48.00%-575.17K | 2,671.61%888.47K | -891.99%-332.29K | -97.81%-872.74K | 384.05%301.37K | -883.60%-1.11M |
| -Change in prepaid assets | -159.94%-132.7K | 108.62%12.65K | -99.68%885 | -46.51%-97.97K | -97.94%24.31K | 143.01%221.38K | 54.66%-146.84K | 275.32%275.16K | 74.76%-66.87K | 1,090.63%1.18M |
| -Change in payables and accrued expense | 123.43%51.35K | 100.05%584 | -191.06%-1.27M | -124.52%-58.68K | -48.53%87.39K | -164.71%-219.13K | -267.17%-1.08M | 616.04%1.39M | 166.49%239.35K | -69.01%169.78K |
| -Change in other current assets | 2,438.73%7.21K | 158.60%1.11K | 66.25%-7.58K | 65.99%-8.52K | -96.25%225 | -96.19%284 | 103.96%430 | -259.20%-22.47K | -2,050.27%-25.06K | 258.22%5.99K |
| -Change in other current liabilities | 66.25%-11.55K | 65.40%-11.34K | 100.56%584 | 313.36%87.45K | 29.31%-19.86K | 24.92%-34.22K | 35.86%-32.78K | 43.05%-103.63K | 143.65%21.16K | 40.37%-28.1K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -169.58%-3.73M | 543.87%13.62M | 8.35%-9.56M | -21.25%-2.58M | 15.05%-2.52M | 44.58%-1.38M | -8.37%-3.07M | 2.32%-10.43M | 27.08%-2.13M | -30.73%-2.97M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 0 | 104.06%6.38K | 0 | 0 | ||||
| Net PPE purchase and sale | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 109.98%6.38K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 104.06%6.38K | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -95.78%250.52K | 2,871.23%15.25M | -30.80%5.97M | -115.00%-486.42K | 0 | 5.94M | 513.18K | -50.97%8.62M | 1,627.78%3.24M | -44.88%5.38M |
| Net common stock issuance | -82.38%1.19M | 6,332.43%13.81M | 14.77%6.15M | -56.21%-813.32K | --0 | --6.75M | --214.68K | -69.78%5.36M | ---520.65K | -39.70%5.88M |
| Proceeds from stock option exercised by employees | --250.52K | 382.02%1.44M | -90.58%307.08K | -99.74%8.58K | --0 | --0 | --298.5K | 6,417.53%3.26M | --3.26M | --0 |
| Net other financing activities | ---- | ---- | ---495K | --318.32K | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -95.78%250.52K | 2,871.23%15.25M | -30.80%5.97M | -115.00%-486.42K | --0 | --5.94M | --513.18K | -50.97%8.62M | 1,627.78%3.24M | -44.88%5.38M |
| Net cash flow | ||||||||||
| Beginning cash position | 811.90%31.28M | -59.11%2.46M | -23.87%6.01M | 11.42%5.4M | 221.16%7.96M | -32.90%3.43M | -23.87%6.01M | 541.90%7.9M | -56.50%4.85M | -33.20%2.48M |
| Current changes in cash | -642.51%-24.71M | 1,229.41%28.87M | -99.40%-3.59M | -375.33%-3.07M | -204.61%-2.52M | 282.25%4.55M | 9.54%-2.56M | -126.68%-1.8M | 134.55%1.11M | -67.81%2.41M |
| Effect of exchange rate changes | 124.19%6.98K | -87.97%-51.02K | 142.36%36.02K | 149.55%122.18K | 17.26%-30.17K | 78.82%-28.85K | -170.19%-27.15K | -4.34%-85.04K | 280.45%48.96K | 14.27%-36.47K |
| End cash Position | -17.30%6.58M | 811.90%31.28M | -59.11%2.46M | -59.11%2.46M | 11.42%5.4M | 221.16%7.96M | -32.90%3.43M | -23.87%6.01M | -23.87%6.01M | -56.50%4.85M |
| Free cash flow | -173.28%-3.78M | 543.87%13.62M | 8.35%-9.56M | -21.25%-2.58M | 15.05%-2.52M | 44.58%-1.38M | -8.37%-3.07M | 2.90%-10.43M | 27.08%-2.13M | -30.73%-2.97M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data